SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4.20 |
Enterprise Value ($M) | 1.38 |
Book Value ($M) | 11.75 |
Book Value / Share | 3.64 |
Price / Book | 0.36 |
NCAV ($M) | 9.69 |
NCAV / Share | 3.00 |
Price / NCAV | 0.43 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.79 |
Return on Assets (ROA) | -0.50 |
Return on Equity (ROE) | -0.53 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.51 |
Current Ratio | 8.51 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.98 |
Assets | 13.04 |
Liabilities | 1.29 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -9.93 |
Net Income | -9.29 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -8.21 |
Cash from Investing | 3.51 |
Cash from Financing | 0.57 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,554 | 12,919 | 12.03 | |
5,382 | 11,308 | 47.59 | |
678 | 374 | 181.28 | |
2,704 | 708 | 381.92 | |
(click for more detail) |
Similar Companies | |
---|---|
APRE – Aprea Therapeutics, Inc. | APTO – Aptose Biosciences Inc. |
APVO – Aptevo Therapeutics Inc. | ASNS – Actelis Networks, Inc. |
ASRT – Assertio Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io